Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Optical CT Technology Evaluated as Adjunct to Mammography for Women with Dense Breasts

By MedImaging staff writers
Posted on 24 Jan 2008
A revolutionary new imaging technology has been designed using laser computed-tomography (CT) to aid in the detection and management of breast cancer.

The CT laser mammography (CTLM) system, developed by Imaging Diagnostic Systems, Inc. More...
(Fort Lauderdale, FL, USA), a manufacturer of laser optical breast cancer imaging systems, is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create three-dimensional (3D) images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression.

CT laser mammography is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth. The company is currently conducting a US clinical trial on the use of CTLM as an adjunct to mammography in patients with dense breasts. The clinical trial is part of the company's effort to seek US Food and Drug Administration (FDA) Premarket Approval (PMA) of the system.

Among the work-in-progress applications the company is working on includes optical fluorescence imaging, assessing the status of presurgical breast cancer chemotherapy treatment compared to magnetic resonance imaging (MRI), and the potential of using laser optical techniques to aid in categorizing types of ductal carcinoma in situ (DCIS).


Related Links:
Imaging Diagnostic Systems

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.